Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAUL D LYONS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Clinical Neurophysiology

NPI
1083656250
CMS profile
4126
Location
WINCHESTER, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$21,167.34

212 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 5; records 51–100 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAUL D LYONS

NPI 1083656250 · CMS profile ID 4126

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Clinical Neurophysiology

WINCHESTER, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1083656250?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAUL D LYONS, NPI 1083656250, CMS profile ID 4126. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1083656250?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). PAUL D LYONS, NPI 1083656250, CMS profile ID 4126. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1083656250?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
PAUL D LYONS, NPI 1083656250, CMS profile ID 4126, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1083656250?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

212 matching records · $21,167.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 212 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 212.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SK Life Science, Inc. $24.3810/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054632830 CMS
SK Life Science, Inc. $0.4010/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054632839 CMS
SK Life Science, Inc. $0.1610/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054632849 CMS
UCB, Inc. $900.0010/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021383769 CMS
UCB, Inc. $13.2410/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021404997 CMS
Otsuka America Pharmaceutical, Inc. $20.5909/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014525063 CMS
PFIZER INC. $10.6209/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050424859 CMS
Biogen, Inc. $20.7709/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012238991 CMS
ABBVIE INC. $2.3509/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997806571 CMS
Horizon Therapeutics plc $21.1109/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987040455 CMS
JAZZ PHARMACEUTICALS INC. $20.3109/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058417381 CMS
MITSUBISHI TANABE PHARMA AMERICA, INC. $20.6809/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038263817 CMS
PFIZER INC. $5.9309/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049103699 CMS
ABBVIE INC. $17.5409/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997806569 CMS
JAZZ PHARMACEUTICALS INC. $6.8809/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058413885 CMS
UCB, Inc. $5.8909/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021404881 CMS
UCB, Inc. $5.7109/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021404837 CMS
Alexion Pharmaceuticals, Inc. $23.4009/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017071409 CMS
Novartis Pharmaceuticals Corporation $24.7909/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992163863 CMS
PFIZER INC. $0.4409/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050477675 CMS
PFIZER INC. $1.9609/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050696663 CMS
LivaNova USA, Inc. $23.9109/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042947215 CMS
PFIZER INC. $15.4709/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049103705 CMS
UCB, Inc. $6.9609/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021404971 CMS
ABBVIE INC. $9.7008/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997806567 CMS
ANI Pharmaceuticals, Inc. $31.6408/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034122871 CMS
JAZZ PHARMACEUTICALS INC. $6.8408/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058411747 CMS
Lundbeck LLC $18.8308/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032278489 CMS
Amneal Pharmaceuticals LLC $25.2908/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053513167 CMS
UCB, Inc. $13.6008/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021405007 CMS
Biogen, Inc. $18.3208/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012283443 CMS
ABBVIE INC. $13.0108/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997806565 CMS
UCB, Inc. $5.8908/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021404873 CMS
Neurelis, Inc. $23.4008/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050923113 CMS
UCB, Inc. $7.3108/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021404979 CMS
UCB, Inc. $20.8208/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021383605 CMS
PFIZER INC. $14.0908/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050686469 CMS
ABBVIE INC. $2.4507/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997806563 CMS
Biogen, Inc. $21.5707/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012262271 CMS
JAZZ PHARMACEUTICALS INC. $6.7307/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058408475 CMS
Inspire Medical Systems, Inc. $24.8507/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058812629 CMS
JAZZ PHARMACEUTICALS INC. $21.3407/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058407609 CMS
Alexion Pharmaceuticals, Inc. $27.5807/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016984901 CMS
SK Life Science, Inc. $21.5907/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054632581 CMS
SK Life Science, Inc. $2.5007/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054632591 CMS
Novartis Pharmaceuticals Corporation $19.9807/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992163861 CMS
UCB, Inc. $900.0007/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021383763 CMS
PFIZER INC. $23.5307/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050582871 CMS
UCB, Inc. $24.8207/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021383612 CMS
UCB, Inc. $720.0006/30/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021383707 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $28,933.30 188
PY2020 $28,268.11 98
PY2021 $23,665.38 109
PY2022 $24,198.68 166
PY2023 $21,167.34 212
PY2024 $30,100.89 216
PY2025 $15,099.93 152

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $85,422.66 28
PY2024 Principal investigator $32,085.22 24
PY2023 Principal investigator $55,416.19 23
PY2022 Principal investigator $16,486.76 10
PY2021 Principal investigator $32,409.75 9
PY2020 Principal investigator $50,753.47 10
PY2019 Principal investigator $261,287.22 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

28 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $3,750.00 12/24/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295030
Principal investigator 1 Janssen Research & Development, LLC $2,275.00 12/17/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295011
Principal investigator 1 SK Life Science, Inc. $2,500.00 12/02/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274997
Principal investigator 1 SK Life Science, Inc. $500.00 12/02/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274999
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $50.00 11/26/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745766
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $563.35 11/26/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745770
Principal investigator 1 Janssen Research & Development, LLC $6,200.00 11/14/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295151
Principal investigator 1 Janssen Research & Development, LLC $600.00 10/20/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295064
Principal investigator 1 Janssen Research & Development, LLC $1,000.00 10/06/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295073
Principal investigator 1 UCB SA $6,500.00 09/24/2025 Non-covered Recipient Entity
Valley Health Diabetes Management Program
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of Staccato alprazolam in STUDY participants 12 years of age and older with stereotypical prolonged seizures No dispute reported 06/30/2026 1246658240
Principal investigator 1 UCB SA $6,500.00 09/22/2025 Non-covered Recipient Entity
Valley Health Diabetes Management Program
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, OUTPATIENT, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF STACCATO ALPRAZOLAM IN STUDY PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH STEREOTYPICAL PROLONGED SEIZURES No dispute reported 06/30/2026 1246658238
Principal investigator 1 Janssen Research & Development, LLC $7,525.00 09/19/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295167
Principal investigator 1 SK Life Science, Inc. $850.00 09/09/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274995
Principal investigator 1 Janssen Research & Development, LLC $1,168.00 09/03/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295182
Principal investigator 1 Janssen Research & Development, LLC $4,950.00 07/28/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295160
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $563.35 07/23/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745774
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $400.00 07/07/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745768
Principal investigator 1 UCB SA $5,593.79 06/16/2025 Non-covered Recipient Entity
WINCHESTER NEUROLOGICAL CONSULTANTS
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of Staccato alprazolam in STUDY participants 12 years of age and older with stereotypical prolonged seizures No dispute reported 06/30/2026 1246658246
Principal investigator 1 UCB SA $145.89 06/16/2025 Non-covered Recipient Entity
WINCHESTER NEUROLOGICAL CONSULTANTS
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, OUTPATIENT, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF STACCATO ALPRAZOLAM IN STUDY PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH STEREOTYPICAL PROLONGED SEIZURES No dispute reported 06/30/2026 1246658996
Principal investigator 1 Janssen Research & Development, LLC $4,975.00 06/13/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295140
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,322.68 05/21/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745776
Principal investigator 1 Janssen Research & Development, LLC $3,750.00 05/16/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295038
Principal investigator 1 Janssen Research & Development, LLC $1,875.00 03/19/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295196
Principal investigator 1 Janssen Research & Development, LLC $1,560.00 02/19/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295099
Principal investigator 1 SK Life Science, Inc. $8,475.00 02/18/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274993
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $3,651.00 01/30/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745772
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,339.60 01/30/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745778
Principal investigator 1 Janssen Research & Development, LLC $6,840.00 01/17/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175294986